Trevena Inc financial data

Symbol
TRVN on OTC
Industry
Pharmaceutical Preparations
Location
955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 361 % -22.3%
Quick Ratio 11.6 % -51.7%
Debt-to-equity -276 % -182%
Return On Equity 211 %
Return On Assets -120 % -66.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 864K shares -94.3%
Common Stock, Shares, Outstanding 855K shares -94.2%
Entity Public Float 12M USD -95.7%
Common Stock, Value, Issued 1K USD -93.3%
Weighted Average Number of Shares Outstanding, Basic 853K shares +52.7%
Weighted Average Number of Shares Outstanding, Diluted 853K shares +52.7%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 1.59M USD +157%
Research and Development Expense 13.1M USD -15.6%
General and Administrative Expense 17.9M USD -16.7%
Costs and Expenses 32.7M USD -13.4%
Operating Income (Loss) -32.1M USD +6.92%
Nonoperating Income (Expense) -1.93M USD -152%
Net Income (Loss) Attributable to Parent -34M USD -10.6%
Earnings Per Share, Basic 6.16 USD/shares +59.2%
Earnings Per Share, Diluted 6.16 USD/shares +59.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD -61.5%
Accounts Receivable, after Allowance for Credit Loss, Current 179K USD
Inventory, Net 900K USD +14.7%
Assets, Current 14.7M USD -62.7%
Property, Plant and Equipment, Net 923K USD -26.7%
Operating Lease, Right-of-Use Asset 3.19M USD -16.3%
Other Assets, Noncurrent 43K USD
Assets 19.2M USD -57.5%
Accounts Payable, Current 918K USD -40.6%
Employee-related Liabilities, Current 2.09M USD +6.51%
Liabilities, Current 6.09M USD -1.14%
Operating Lease, Liability, Noncurrent 3.59M USD -23.3%
Liabilities 42.5M USD +2.2%
Retained Earnings (Accumulated Deficit) -606M USD -5.96%
Stockholders' Equity Attributable to Parent -23.3M USD -757%
Liabilities and Equity 19.2M USD -57.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.42M USD +13.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 855K shares -94.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.42M USD +13.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.1M USD -60.3%
Deferred Tax Assets, Valuation Allowance 157M USD +6.24%
Deferred Tax Assets, Gross 157M USD +6.27%
Operating Lease, Liability 4.68M USD -17.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.1M USD +11%
Lessee, Operating Lease, Liability, to be Paid 5.5M USD -20.8%
Property, Plant and Equipment, Gross 3.79M USD -10.7%
Operating Lease, Liability, Current 1.09M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.5M USD +1.63%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.47M USD +1.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 821K USD -36.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.52M USD +1.67%
Deferred Tax Assets, Operating Loss Carryforwards 55.8M USD +20.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 640K USD -58%
Operating Lease, Payments 122K USD -4.69%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 88K USD +7.32%
Share-based Payment Arrangement, Expense 681K USD -15.5%
Interest Expense 2.9M USD -99.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%